Letter

How much will Herceptin really cost?

BMJ 2006; 333 doi: 10.1136/bmj.39052.480231.FA (Published 7 December 2006)
Cite this as: BMJ 2006;333:1219.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

The money is already there

  1. Rubin Minhas, general practitioner
  1. 1Sunlight Medical Centre, Gillingham, Kent ME7 1LX anything@rubin.icom43.net

    Barrett et al state that “the real cost of Herceptin is in the other patients not treated, whether they are patients with cancer or those with other conditions”—the opportunity cost.1 The competing demands that medical professionals across multiple disciplines place on limited resources and their responsibility to ensure the judicious use of publicly funded resources should also have been acknowledged.

    It is too easy to blame the National Institute for Health and Clinical Excellence (NICE) when healthcare professionals can enable judicious use of what has already …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular